OccuRx's Series A Round

OccuRx raised a round of funding on May 19, 2015.

OccuRx is focused on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis. Fibrosis and inflammation are progressive and path…

Articles about OccuRx's Series A Round: